Tenaya Therapeutics (NASDAQ:TNYA) Given New $5.00 Price Target at Morgan Stanley
Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) had its price target dropped by investment analysts at Morgan Stanley from $15.00 to $5.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Other equities analysts also recently issued reports about the company. Chardan Capital dropped […]
Tenaya Therapeutics (NASDAQ:TNYA – Get Free Report) had its price target dropped by investment analysts at Morgan Stanley from $15.00 to $5.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the stock. Other equities analysts also recently issued reports about the company. Chardan Capital dropped […]
